What are the best ways to manage side effects associated with EGFR and ALK inhibitors?

Beth Eaby-Sandy, MSN, CRNP, OCN, and Elizabeth Waxman, RN, MSN, AOCN, ANP-BC

Beth Eaby-Sandy, MSN, CRNP, OCN, and Elizabeth Waxman, RN, MSN, AOCN, ANP-BC, on advances in targeted treatments for non–small cell lung cancer.


Copyright © 2016 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer
Bot trap - Don't go here